Literature DB >> 21493241

Complications in pediatric deep neck space abscesses.

Cristina M Baldassari1, Rebecca Howell, Melissa Amorn, Ross Budacki, Sukgi Choi, Maria Pena.   

Abstract

OBJECTIVES: To determine the incidence and demographic profile of children who develop complications from deep neck space abscess. STUDY
DESIGN: Case series.
SETTING: Tertiary children's hospital. SUBJECTS AND METHODS: One hundred thirty-eight patients admitted for deep neck space abscesses between 1998 and 2008. Inclusion criteria were age younger than 18 years and computed tomography scan demonstrating an abscess in the retropharyngeal, parapharyngeal, or peritonsillar spaces. Children were diagnosed with abscess if purulence was encountered on operative incision and drainage.
RESULTS: In the first 5 years of the study, 45 children met the inclusion criteria, whereas in the latter 5 years, 93 children were treated for abscesses. There were no differences between these cohorts in terms of age (P = .70), gender (P = .08), abscess site (P = .23), or rate of surgical intervention (P = .83). The total major complication rate was 9.4% (n = 13) with mediastinitis being the most frequent (n = 9) complication. The number of complications between the first (n = 3) and second (n = 10) groups was not significantly different (P = .55). The factors that predisposed patients to develop complications were younger age at presentation and retropharyngeal abscess location. Children with complications were more likely to have Staphylococcus aureus identified as the causative organism (P = .007). Only 1 of 4 children with methicillin-resistant S aureus had a complicated clinical course.
CONCLUSIONS: Deep neck space abscesses continue to cause significant morbidity in children. Factors that predict complications include young age, retropharyngeal location, and S aureus. Providers must maintain a high index of suspicion to promptly diagnose and treat these complications.

Entities:  

Mesh:

Year:  2011        PMID: 21493241     DOI: 10.1177/0194599810393882

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  8 in total

1.  Anatomical and histological study of the deep neck fasciae: does the alar fascia exist?

Authors:  M Gavid; J M Dumollard; C Habougit; Y Lelonge; F Bergandi; M Peoc'h; J M Prades
Journal:  Surg Radiol Anat       Date:  2018-01-29       Impact factor: 1.246

2.  Zygomatic haematoma in an 11-month-old helps diagnose retropharyngeal abscess, with concurrent tonsillitis and subsequent infant tonsillectomy.

Authors:  David H Collis; Ameeth Sanu
Journal:  BMJ Case Rep       Date:  2016-09-20

3.  Descending necrotizing mediastinitis in an infant.

Authors:  Michael Butterfield; Kenshata Watkins; Enrique Palacios
Journal:  West J Emerg Med       Date:  2015-03-02

Review 4.  Paediatric Deep Neck Infection-The Risk of Needing Intensive Care.

Authors:  Vojtech Perina; David Szaraz; Hana Harazim; Milan Urik; Eva Klabusayova
Journal:  Children (Basel)       Date:  2022-06-29

5.  Role of steroids in conservative treatment of parapharyngeal and retropharyngeal abscess in children.

Authors:  Eva Villanueva-Fernández; R Casanueva-Muruáis; A Vivanco-Allende; J L Llorente; A Coca-Pelaz
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-06-29       Impact factor: 3.236

6.  Epidemiology and Clinical Features of Peritonsillar Abscess: Is It Related to Seasonal Variations?

Authors:  Nurullah Seyhun; Zeynep Aslı Batur Çalış; Merve Ekici; Suat Turgut
Journal:  Turk Arch Otorhinolaryngol       Date:  2018-12-01

7.  Management of pediatric peritonsillar and deep neck infections- cross- sectional retrospective analysis.

Authors:  Ana Sousa Menezes; Daniela Correia Ribeiro; Joana Rocha Guimarães; António Fontes Lima; Luís Dias
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2019-10-18

8.  Clinical characteristics for conservative therapy of pediatric parapharyngeal abscesses.

Authors:  Jing Bi; Xiaowei Chen; Zhiying Zhou; Yong Fu
Journal:  Braz J Otorhinolaryngol       Date:  2019-12-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.